Passage Bio
PASG
48 hedge funds and large institutions have $21.3M invested in Passage Bio in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 6 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.1% less ownership
Funds ownership: 3.05% → 2.95% (-0.1%)
11% less funds holding
Funds holding: 54 → 48 (-6)
32% less capital invested
Capital invested by funds: $31.4M → $21.3M (-$10.1M)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$164K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$96.1K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$82.1K |
| 4 |
Morgan Stanley
New York
|
+$54K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$21.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$803K |
| 2 |
D.E. Shaw & Co
New York
|
-$102K |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$75.4K |
| 4 |
Millennium Management
New York
|
-$74.8K |
| 5 |
AC
Annandale Capital
Dallas,
Texas
|
-$51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIC
51
Cornercap Investment Counsel
Atlanta,
Georgia
| – | -$46.8K | -2,488 | Closed |
|
52
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$23.2K | -1,235 | Closed |
|
|
V
53
Veritable
Wilmington,
Delaware
| – | -$21.7K | -1,152 | Closed |
|
|
TSS
54
Two Sigma Securities
New York
| – | -$19.4K | -1,030 | Closed |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$509 | -31 | -94% |
|
|
CA
56
Clearstead Advisors
Cleveland,
Ohio
| – | -$71 | -4 | Closed |
|
PASG Hedge Fund Activity: Q3 2023 in Review
48 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q3 2023, worth a combined $21.3M — down 32% from $31.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PASG and 1 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 14 added.
The largest buyer was Erste Asset Management, adding an estimated $164K. The largest seller was Lynx1 Capital Management, cutting an estimated $803K.
- 48 institutional investors held Passage Bio (PASG) as of Q3 2023, down from 54 in Q2 2023.
- Funds reported $21.3M of Passage Bio stock for Q3 2023, down 32% quarter-over-quarter.
- 1 fund opened new Passage Bio positions in Q3 2023 and 6 closed out, a net change of -5 holders.
- The largest Passage Bio buyer in Q3 2023 was Erste Asset Management, an estimated $164K added.
- The largest Passage Bio seller in Q3 2023 was Lynx1 Capital Management, an estimated $803K sold.
Based on aggregated 13F filings for Q3 2023.